GlassScriptPhysician profile
Malika S Oglesby
NPI 1386931491
$386.70
in general payments reported to CMS, 2019-2025
10 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.81 · 2020: $16.72 · 2022: $61.07 · 2023: $53.89 · 2024: $67.91 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $113.65 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $78.32 | 2022-2025 | Gardasil 9, Vaxelis, Enflonsia |
| Cranial Technologies, INC | $50.60 | 2022-2025 | Doc Band |
| Sobi, INC | $30.86 | 2022 | |
| Biocryst US Sales Co., LLC | $25.63 | 2025 | Orladeyo |
| Pfizer INC. | $20.16 | 2023 | |
| Genentech USA, INC. | $20.14 | 2025 | Xolair |
| Hologic Sales and Service, LLC | $17.81 | 2023 | Aptima, Thinprep 2000 Processor |
| Ironshore Pharmaceuticals INC. | $16.72 | 2020 | |
| Phadia US INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malika Oglesby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.